Industry News
Potential Biomarker Identified For Aggressive Colon Cancer
Jun 06, 2013
MET protein levels correlate strongly with epithelial-mesenchymal transition (EMT) phenotype, a treatment-resistant type of colorectal cancer and may be used as a surrogate biomarker, according to new research from The University of Texas MD Anderson Cancer Center... Read More
Test Developed To Identify Unsafe Stem Cells
Jun 06, 2013
The breakthrough is a significant step in improving the quality of iPS cells and identifying unwanted cells that can form tumours. The test also determines how stable iPS cells are when grown in the lab. Dr Andrew Laslett and his team have spent the last five years working on the project. The research has focused on comparing different types of iPS cells with human embryonic stem cells... Read More
Discussing Death With Patients The Most Stressful Part Of Oncology
Jun 06, 2013
A group of oncologists have revealed in a new study by Ben-Gurion University of the Negev (BGU) researchers that communicating about death and dying with their patients is one of the most difficult and stressful parts of their work. In the United States, 577,190 deaths from cancer occurred in 2012, according to the American Cancer Society... Read More
New Class Of Molecules May Be Key To Emerging 'Enhancer Therapy'
Jun 06, 2013
In a pair of distinct but complementary papers, researchers at the University of California, San Diego School of Medicine and colleagues illuminate the functional importance of a relatively new class of RNA molecules... Read More
Potential New Clues For Identifying Breast Cancer Risk
Jun 06, 2013
New research provides critical insights into how normal breast precursor cells may be genetically vulnerable to develop into cancer. The research is published in the inaugural issue of Stem Cell Reports, an open-access journal from the International Society of Stem Cell Research (ISSCR) published by Cell Press... Read More
Genetic Variations Impact Warfarin Doses For African Americans
Jun 06, 2013
A common genetic variation that can impact the therapeutic dose of the blood-thinning drug warfarin among African Americans has been found, according to a new report in The Lancet... Read More
New Strategy For Defeating Neuroblastoma
Jun 05, 2013
Researchers at Karolinska Institutet in Sweden have found a promising strategy for defeating neuroblastoma - a malignant form of cancer in children - that focuses on the so-called MYCN protein. A specific chemical molecule helps to break down MYCN, which either kills the cancer cell or makes it mature into a harmless neuron... Read More
New Drug Target Identified In Deadly Form Of Leukemia
Jun 05, 2013
A research team led by the Duke-NUS Graduate Medical School (Duke-NUS) in Singapore has identified ways to inhibit the function of a key protein linked to stem cell-like behavior in terminal-stage chronic myeloid leukemia (CML), making it possible to develop drugs that may extend the survival of these patients... Read More
Genetic Signature Of Deadly Brain Cancer Identified
Jun 05, 2013
A multi-institutional team of researchers have pinpointed the genetic traits of the cells that give rise to gliomas - the most common form of malignant brain cancer. The findings, which appear in the journal Cell Reports, provide scientists with rich new potential set of targets to treat the disease... Read More
How And Where Breast Tumor Cells Become Dormant And What Causes Them To Become Metastatic
Jun 05, 2013
The long-standing mystery behind dormant disseminated breast tumor cells and what activates them after years and even decades of latency may have been solved. Researchers with the U.S... Read More
Previous Page Next Page